Edward B. Smith III - 30 Dec 2021 Form 4 Insider Report for HEAT BIOLOGICS, INC. (SCPX)

Role
Director
Signature
/s/ Edward B. Smith III
Issuer symbol
SCPX
Transactions as of
30 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Jan 2022, 16:19:17 UTC
Previous filing
15 Dec 2021
Next filing
09 Dec 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHWK Stock Option (right to buy) Other $0 -32,467 -100% $0.000000* 0 30 Dec 2021 Common Stock 32,467 $4.06 Direct F1
transaction NHWK Stock Option (right to buy) Award $0 +32,467 $0.000000 32,467 30 Dec 2021 Common Stock 32,467 $4.06 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 30, 2021, the board of directors of Heat Biologics, Inc. (the "Company") rescinded and cancelled stock option awards previously made to Mr. Smith on December 13, 2021 covering 32,467 shares under the Company's 2018 Stock Incentive Plan (the "Plan") and granted new stock options under the Plan, on substantially similar terms to the rescinded stock options, which new stock options are subject to forfeiture in the event an amendment to increase the number of shares of common stock available for grant under the Plan is not adopted by the Company's stockholders.
F2 These stock options vest pro rata on a monthly basis over a twelve- month period commencing 1/13/2022.